Naltrexone as an Antipruritic Agent for Surgical Scar Pruritus. [PDF]
CureusFlorez M +3 more
europepmc +1 more source
Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis. [PDF]
Obes Sci PractRyan DH +5 more
europepmc +1 more source
High Prevalence and Low Incidence of Constipation Among Glucagon-Like Peptide-1 Receptor Agonist Users. [PDF]
Clin Gastroenterol HepatolChang M +3 more
europepmc +1 more source
Efficacy of Low-Dose Naltrexone in Women With Fibromyalgia Syndrome: A 12-Month Randomised, Double-Blind, Placebo-Controlled Single-Centre Clinical Trial (INNOVA Study). [PDF]
Eur J PainRodríguez-Freire C +7 more
europepmc +1 more source
Medicaid Managed Care Plan Alignment With State Substance Use Disorder Treatment Coverage Requirements. [PDF]
Milbank QFeltus SR +6 more
europepmc +1 more source
Optimizing outpatient pharmacologic treatment for veterans with alcohol use disorder using an academic detailing approach for primary care providers in the United States Department of Veterans Affairs: A retrospective quasi-experimental study. [PDF]
AddictionBounthavong M +10 more
europepmc +1 more source
A Membrane-Centric Plasma Lipidomic Signature of Response to Long-Acting Naltrexone in Alcohol Use Disorder. [PDF]
Addict BiolHuang L +5 more
europepmc +1 more source
Effect of Naltrexone HCl and Bupropion HCl (Contrave) Extended-Release Tablet (NB-ER) for Weight Maintenance in Adult Patients After a 6-Month Intensive Behaviour Modification Program Combined With Meal Replacements. [PDF]
Clin ObesChetty VT +6 more
europepmc +1 more source